PF-06651600

Pfizer may have a lot going on in immunology, but all its drugs could be beaten by rivals: analyst
Fierce Pharma
Thu, 07/9/20 - 10:21 pm
Pfizer
immunology
abrocitinib
Xeljanz
PF-06651600
Pfizer begins phase 2b/3 trial of PF-06651600 to treat alopecia areata
Pharmaceutical Business Review
Fri, 01/4/19 - 09:12 am
Pfizer
clinical trials
PF-06651600
JAK3 inhibitors
alopecia areata
Pfizer’s JAK inhibitors improve hair regrowth in patients with alopecia areata
Pharmaceutical Business Review
Mon, 09/17/18 - 09:52 am
Pfizer
JAK inhibitors
alopecia areata
clinical trials
PF-06651600
PF-06700841